NCT05120284
Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 18 versions: 14 with changes below, 4 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 11 words Show 4 more changesShow less
- Trial completed
- Primary completion date changed from estimate of Jul 1, 2026 to Aug 31, 2026
- Enrollment target: estimated 40 to confirmed 37
- Publications: details revised at 40 of 42 entries
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised at 2 of 2 sites
- Notable Primary completion date: Jun 2025 to Jul 1, 2026
- Study completion date: Jun 2025 to Aug 31, 2026
- Minor Study sites: 3 to 2v13
- Minor Collaborators shortened, about 5 wordsv12
Show 8 earlier versionsHide 8 earlier versions
- Minor Site details revised at 1 of 3 sitesv11
- Minor Site details revised at 1 of 3 sitesv10
- Notable Eligibility criteria expanded, about 21 words
- Primary endpoint revised
- Study sites revised (3)
- Minor Site details revised at 1 of 3 sitesv7
- Notable Eligibility criteria expanded, about 27 words
- Study sites: 1 to 3
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Jun 2022 to Jul 1, 2022
- Site details revised
- Notable Start date: Mar 2022 to Jun 2022v3
- Minor Study site revisedv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Level of phosphorylated PDC protein expressed in surgical tissue
Timeframe: Within 4 weeks post surgery
Arms and interventions
Pre-Surgical Dichloroacetate (DCA)Active comparator
Study medication begins in subjects randomized to preoperative DCA. All subjects will be given the 12.5 mg/kg/12 hour DCA for pre-surgical dosing. Post-surgery the GSTZ1 haplotype will be utilized to dose all patients.
No Pre-Surgical Dichloroacetate (DCA)Active comparator
Subject randomized to start DCA after surgery will do so 12-24 hours postoperatively, depending on their ability to safely receive medication.
Drugs: Dichloroacetate (DCA)
Genetic: Genotype
Sites
2 sites in 1 country